COLLEGIUM PHARMACEUTICAL, INC — Director's Dealing 2021

Jan 22, 2021

SEC Form 4/A — Form 4/A

Issuer: COLLEGIUM PHARMACEUTICAL, INC (COLL)
CIK: 0001267565
Period of Report: 2021-01-19

Reporting Person: Malamut Richard (EVP and Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-01-19	Common Stock	A	36960	—	Acquired	96790	Direct
2021-01-19	Common Stock	A	2187	—	Acquired	98977	Direct

Footnotes

F1: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2022, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock.

F2: On January 19, 2021, the Compensation Committee of the Board of Directors of the issuer determined that performance-vesting criteria were met with regard to 2,187 performance share units granted in a prior year.